Gladstone NOW: The Campaign Join Us on the Journey ✕
211 - 225 of 407 Results Clear All
Here are five safe ways to enjoy the holidays and connect with your loved ones at a distance
Communications Gladstone Experts
San Francisco Chronicle—Associate Investigator Nadia Roan, PhD, comments on recent findings by her group and others that COVID-19 patients retain immune cells against the new coronavirus for several months after infection, which bodes well for the ability of vaccines to provide lasting protection against the disease.
Gladstone Experts COVID-19 Infectious Disease Roan Lab
The Wall Street Journal—Chief Information Officer Scott Pegg explains how his IT team adapted quickly to the COVID-19 pandemic to provide Gladstone researchers with the computing and storage power they needed to work on large data sets—in particular image data—from their homes.
Information Technology Gladstone Experts
Roan uses single-cell analyses to study HIV infection and the immune system
Gladstone Experts Institutional News News Release Profile COVID-19 HIV/AIDS Infectious Disease Roan Lab Single Cell
Nature—Melanie Ott, MD, PhD, director of the Gladstone Institute of Virology, explains how the CRISPR-based coronavirus test she recently developed with Nobel Laureate and Senior Investigator Jennifer Doudna, PhD, measures up against conventional, PCR-based tests.
Gladstone Experts COVID-19 Infectious Disease Doudna Lab Ott Lab CRISPR/Gene Editing
USA Today—California Proposition 14 put funding for the Stem Cell Research Institute on the ballot this year. Gladstone President Deepak Srivastava, MD, explains how previous funding for stem cell research in California has helped bring the field to a point where stem cell–based therapies are now possible.
Gladstone Experts Cardiovascular Disease Srivastava Lab Stem Cells/iPSCs
TED—In a March talk selected this week for the TED homepage, Senior Investigator Leor Weinberger, PhD, describes an intriguing type of vaccine his lab is developing and that, like the viruses it aims to neutralize, can mutate and spread from person to person.
Gladstone Experts HIV/AIDS Center for Cell Circuitry Infectious Disease Weinberger Lab
USA Today—Senior Investigator and Nobel Laureate Jennifer Doudna, PhD, shares her view of CRISPR-based coronavirus detection kits and the possibility they might be deployed during the current pandemic. She and Senior Investigator Melanie Ott, MD, PhD, recently described the test they developed together in a publication posted on the electronic preprint platform bioRxiv.
Gladstone Experts COVID-19 Data Science and Biotechnology Infectious Disease Doudna Lab Ott Lab CRISPR/Gene Editing
San Francisco Chronicle—Senior Investigator Warner Greene, MD, PhD, endorses presidential candidate Joe Biden's plan to fight the coronavirus pandemic, calling the plan “rational.”
Gladstone Experts COVID-19 Center for HIV Cure Research Greene Lab
San Francisco Chronicle—Some of the treatments the president received for COVID-19 were developed using cells derived from human embryonic tissue. In addition, many of the COVID-19 vaccine candidates were developed using fetal cell lines. Gladstone Senior Investigator Warner Greene explains how valuable fetal tissue research has been to research on cancer, HIV, spinal cord injuries, and many other diseases. He also describes how the president’s 2019 decision to cut federal funding for fetal cell research has damaged that progress.
Gladstone Experts COVID-19 Infectious Disease Greene Lab
abc News—In 2019, the Trump administration suspended federal funding for research involving fetal tissue. Gladstone President Deepak Srivastava explains that if the funding ban had been in place over the last few decades, many important drugs—including treatments for COVID-19—would not have been developed.
Gladstone Experts COVID-19 Roddenberry Stem Cell Center Srivastava Lab Stem Cells/iPSCs
Science is Fun!—Director of the Gladstone Institute of Virology Melanie Ott describes her latest work developing a CRISPR-based test for COVID-19, and the prospect for broadly acting antiviral therapeutics.
Gladstone Experts COVID-19 Infectious Disease Ott Lab
abc News—Gladstone President Deepak Srivastava, MD, comments on the fact that the experimental treatments President Trump received for COVID-19 were tested on cells that were derived from fetal tissue decades ago, and expresses concern that the Trump administration's current ban on the use of fetal tissue for research could slow efforts to curb the pandemic.
Gladstone Experts COVID-19 Cardiovascular Disease Srivastava Lab
POZ—Finding a cure to HIV will require a full understanding of the latent reservoir, the population of cells in which the virus hides, evading antiretroviral therapy. Gladstone scientist Nadia Roan describes her recent work mapping an atlas of the reservoir, and how it provides hope that new therapies could be developed to target and eliminate reservoir cells.
Gladstone Experts HIV/AIDS Infectious Disease Roan Lab
The New York Times—The experimental drugs used to treat President Trump for COVID-19 were developed with the help of a human cell line derived from a fetus aborted decades ago. Gladstone President Deepak Srivastava, MD, and Senior Investigator Warner Greene, MD, PhD, comment on the ethics of accepting this treatment while also banning research using newly derived fetal cells, in the process thwarting the development of life-saving treatments for other conditions.
Gladstone Experts COVID-19 Cardiovascular Disease Center for HIV Cure Research Greene Lab Srivastava Lab
